文献速递类风湿关节炎

ADAM15在滑膜成纤维细胞凋亡抵抗中的作用:通过钙调蛋白募集将Fas/CD95死亡信号转化为促生存通路激活

ADAM15 in Apoptosis Resistance of Synovial Fibroblasts: Converting Fas/CD95 Death Signals Into the Activation of Prosurvival Pathways by Calmodulin Recruitment.
PubMed 文献 · Arthritis Rheumatol · 2018-11-20

研究探讨ADAM15将FasL介导的死亡信号转化为Src和黏着斑激酶(FAK)促生存激活的机制。在类风湿关节炎滑膜成纤维细胞(RASFs)和ADAM15转染的T/C28a4细胞中,Fas/CD95触发后ADAM15依赖性地促进Src和FAK磷酸化并与生存增加相关。钙调蛋白(CaM)抑制剂三氟拉嗪或CRAC/Orai抑制剂BTP-2与FasL同时应用可协同增强Fas介导的RASFs凋亡。

要点

  • ADAM15缺失胞质结构域或RNA干扰沉默ADAM15可增加FasL刺激后的凋亡。
  • Fas连接触发CRAC/Orai1通道依赖的CaM募集至细胞膜Fas/CD95和ADAM15。
  • CaM抑制剂三氟拉嗪或CRAC/Orai抑制剂BTP-2与FasL同时应用协同增强RASFs凋亡。

核心结论

  • ADAM15为FasL诱导死亡信号经CRAC/Orai共激活后形成CaM依赖性促生存信号复合物提供支架,并可能是打破RASFs凋亡抵抗的潜在治疗靶点。

研究设计与样本

  • 研究在RASFs和ADAM15转染的T/C28a4细胞中进行,采用酶测定和膜联蛋白V染色检测Caspase 3/7活性和凋亡率,免疫印迹分析磷酸化Src和FAK,CaM-Sepharose pull-down和特异抗体共免疫沉淀分析ADAM15与CD95同CaM、Src或FAK的相互作用,重组CaM和ADAM15蛋白结合实验,免疫荧光研究ADAM15、Fas/CD95和CaM的亚细胞共定位。

主要发现

  • 与转染全长ADAM15的细胞相比,转染缺乏胞质结构域ADAM15构建体的细胞在FasL刺激后凋亡增加。
  • RNA干扰沉默ADAM15后RASFs的凋亡抵抗降低。
  • Fas连接触发CRAC/Orai1通道依赖的CaM募集至细胞膜Fas/CD95和ADAM15,同时与CaM结合的Src参与含胞质结合FAK的ADAM15复合物。
  • RASFs中Fas连接导致ADAM15依赖的Src和FAK磷酸化,并与生存增加相关。
  • CaM抑制剂三氟拉嗪或CRAC/Orai抑制剂BTP-2与FasL同时应用可协同增强RASFs中Fas介导的凋亡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate mechanisms underlying the capability of ADAM15 to transform FasL-mediated death-inducing signals into prosurvival activation of Src and focal adhesion kinase (FAK) in rheumatoid arthritis synovial fibroblasts (RASFs). METHODS: Caspase 3/7 activity and apoptosis rate were determined in RASFs and ADAM15-transfected T/C28a4 cells upon Fas/CD95 triggering using enzyme assays and annexin V staining. Phosphorylated Src and FAK were analyzed by immunoblotting. Interactions of ADAM15 and CD95 with calmodulin (CaM), Src, or FAK were analyzed by pull-downs using CaM-Sepharose and coimmunoprecipitations with specific antibodies. Protein binding assays were performed using recombinant CaM and ADAM15. Immunofluorescence was performed to investigate subcellular colocalization of ADAM15, Fas/CD95, and CaM. RESULTS: The antiapoptotic effect of ADAM15 in FasL-stimulated cells was demonstrated either by increased apoptosis of cells transfected with an ADAM15 construct lacking the cytoplasmic domain compared to cells transfected with full-length ADAM15 or by reduced apoptosis resistance of RASFs upon RNA interference silencing of ADAM15. Fas ligation triggered a Ca2+ release-activated Ca2+ /calcium release-activated calcium channel protein 1 (CRAC/Orai1) channel-dependent CaM recruitment to Fas/CD95 and ADAM15 in the cell membrane. Simultaneously, Src associated with CaM was shown to become engaged in the ADAM15 complex also containing cytoplasmic-bound FAK. Accordingly, Fas ligation in RASFs led to ADAM15-dependent phosphorylation of Src and FAK, which was associated with increased survival. Pharmacologic interference with either the CaM inhibitor trifluoperazine or the CRAC/Orai inhibitor BTP-2 simultaneously applied with FasL synergistically enhanced Fas-mediated apoptosis in RASFs. CONCLUSION: ADAM15 provides a scaffold for formation of CaM-dependent prosurvival signaling complexes upon CRAC/Orai coactivation by FasL-induced death signals and a potential therapeutic target to break apoptosis resistance in RASFs.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Janczi T, Böhm BB, Fehrl Y, et al. ADAM15 in Apoptosis Resistance of Synovial Fibroblasts: Converting Fas/CD95 Death Signals Into the Activation of Prosurvival Pathways by Calmodulin Recruitment. Arthritis Rheumatol. 2018. PMID: 30003689. doi:10.1002/art.40667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。